Overview / Abstract: |
Despite evidence-based interventions to prevent or manage heart failure (HF), poor HF-related outcomes persist as evidenced by the number of preventable HF-related hospitalizations and high readmission rates. Moreover, the economic burden that HF places on the health care system is significant. Pharmacists can improve adherence to guideline recommendations for the use of intravenous (IV) iron therapy for patients with HF and iron deficiency (ID) and develop treatment pathways and implement formulary strategies that make IV iron available to patients. These conference highlights include brief lectures and case discussions that outline the role of pharmacists in improving the recognition and treatment of ID in HF along with strategies to avoid suboptimal outcomes and overcome common barriers. |
Expiration |
Nov 17, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1.25 |
Accreditation |
ACPE |
Presenters / Authors / Faculty |
Stormi Gale, PharmD, BCCP, BCPS, FHFSA B. Andrew Mardis, PharmD, BCCP, BCTXP, BCPS Muthiah Vaduganathan, MD, MPH |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from American Regent, Inc. |
Keywords / Search Terms |
ACHL ACHL, CPE, CE, Continuing Medical Education, CPE/CE, Iron Deficiency, Heart Failure, Managed Care Pharmacists, anemia, iron replacement, HFrEF, Stormi Gale, PharmD, B. Andrew Mardis, PharmD, Muthiah Vaduganathan, MD Free CE CME |